(Post-pandemic Era)-Global Remicade Biosimilar Market Segment Research Report 2022
- Published Date: 2022-04-19
- Report ID: 128266
- Pages: 175
-
Format:
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. XYZResearchreleased the Global Remicade Biosimilar Market Segment Research Report 2022, which aims to sort out the development status and trends of the Remicade Biosimilar industry at home and abroad, estimate the overall market scale of the Remicade Biosimilar industry and the market share of major countries, analyze the development potential of each segment of the Remicade Biosimilar industry, and study and judge the downstream market demand of Remicade Biosimilar through systematic research, Analyze the competition pattern of Remicade Biosimilar, so as to help solve the pain points of various stakeholders in Remicade Biosimilar industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Remicade Biosimilar Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Remicade Biosimilar Market
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Fosun Pharmaceutical
Livzon Pharmaceutical
Anke Biotechnology
Hualan Biological Engineering
Walvax Biotechnology
Hisun Pharmaceutical
Major Type of Remicade Biosimilar Covered in XYZResearch report:
100mg/10ml
500mg/50ml
Application Segments Covered in XYZResearch Market
Blood Disorders
Oncology Diseases
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Remicade Biosimilar Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Remicade Biosimilar Market by Value
2.2.1 Global Remicade Biosimilar Revenue by Type
2.2.2 Global Remicade Biosimilar Market by Value (%)
2.3 Global Remicade Biosimilar Market by Production
2.3.1 Global Remicade Biosimilar Production by Type
2.3.2 Global Remicade Biosimilar Market by Production (%)
3. The Major Driver of Remicade Biosimilar Industry
3.1 Historical & Forecast Global Remicade Biosimilar Demand
3.2 Largest Application for Remicade Biosimilar (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Remicade Biosimilar Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Remicade Biosimilar Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Remicade Biosimilar Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Remicade Biosimilar Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Remicade Biosimilar Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Remicade Biosimilar Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Remicade Biosimilar Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Remicade Biosimilar Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Remicade Biosimilar Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Remicade Biosimilar Average Price Trend
12.1 Market Price for Each Type of Remicade Biosimilar in US (2018-2022)
12.2 Market Price for Each Type of Remicade Biosimilar in Europe (2018-2022)
12.3 Market Price for Each Type of Remicade Biosimilar in China (2018-2022)
12.4 Market Price for Each Type of Remicade Biosimilar in Japan (2018-2022)
12.5 Market Price for Each Type of Remicade Biosimilar in India (2018-2022)
12.6 Market Price for Each Type of Remicade Biosimilar in Korea (2018-2022)
12.7 Market Price for Each Type of Remicade Biosimilar in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Remicade Biosimilar Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Remicade Biosimilar
14. Remicade Biosimilar Competitive Landscape
14.1 Synthon Pharmaceuticals
14.1.1 Synthon Pharmaceuticals Company Profiles
14.1.2 Synthon Pharmaceuticals Product Introduction
14.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 LG Life Sciences
14.2.1 LG Life Sciences Company Profiles
14.2.2 LG Life Sciences Product Introduction
14.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Novartis (Sandoz)
14.3.1 Novartis (Sandoz) Company Profiles
14.3.2 Novartis (Sandoz) Product Introduction
14.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Celltrion
14.4.1 Celltrion Company Profiles
14.4.2 Celltrion Product Introduction
14.4.3 Celltrion Remicade Biosimilar Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Biocon
14.5.1 Biocon Company Profiles
14.5.2 Biocon Product Introduction
14.5.3 Biocon Remicade Biosimilar Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Hospira
14.6.1 Hospira Company Profiles
14.6.2 Hospira Product Introduction
14.6.3 Hospira Remicade Biosimilar Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Merck Serono (Merck Group)
14.7.1 Merck Serono (Merck Group) Company Profiles
14.7.2 Merck Serono (Merck Group) Product Introduction
14.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Biogen idec Inc.
14.8.1 Biogen idec Inc. Company Profiles
14.8.2 Biogen idec Inc. Product Introduction
14.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Genentech (Roche Group)
14.9.1 Genentech (Roche Group) Company Profiles
14.9.2 Genentech (Roche Group) Product Introduction
14.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Fosun Pharmaceutical
14.10.1 Fosun Pharmaceutical Company Profiles
14.10.2 Fosun Pharmaceutical Product Introduction
14.10.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Livzon Pharmaceutical
14.12 Anke Biotechnology
14.13 Hualan Biological Engineering
14.14 Walvax Biotechnology
14.15 Hisun Pharmaceutical
15. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
